PD18-04 UROLIFT AND REZUM: A COMPARISON OF DEVICE RELATED ADVERSE EVENTS IN A NATIONAL REGISTRY

INTRODUCTION AND OBJECTIVE:Urolift and Rezum have demonstrated efficacy as minimally invasive surgical therapies (MIST) for the treatment of benign prostatic hyperplasia (BPH). Both modalities can ...